Methods and systems for porting tissue-based classifiers into liquid biopsy samples

CA3328168A1Pending Publication Date: 2025-12-04GENECENTRIC THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3328168
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-28
Filing Date
2025-05-28
Publication Date
2025-12-04
Patent Text Reader

Abstract

The present disclosure discloses methods for assigning gene expression signature labels to samples with liquid circulating tumor DNA (ctDNA) fragmentomics profiles and using said profiles to uncover genes whose expression patterns are reproducible between tissue samples and bodily fluid samples comprising ctDNA. Also provided herein are methods and systems for generating classifiers for a desired feature of a cancer of interest in a subject suffering from said cancer of interest.
Need to check novelty before this filing date? Find Prior Art